Triple antiplatelet tx increases bleeding and no better than standard therapy for preventing TIA and recurrent CVA (TARDIS)

Triple antiplatelet tx increases bleeding and no better than standard therapy for preventing TIA and recurrent CVA (TARDIS) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central